hydrazine has been researched along with Virus Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, A; Alonso, R; Alvarez-Román, MT; Arrieta-Cerdán, E; Bastida, JM; Bernat, S; Bolaños, E; Caparrós, I; Entrena, L; Fernández-Fuentes, F; García-Frade, J; Gómez-Nuñez, M; González-López, TJ; González-Porras, JR; Hernández-Rivas, JA; Lopez-Ansoar, E; Martínez-Badas, MP; Martínez-Robles, V; Olivera, P; Pascual, C; Pérez-Rus, G; Sánchez-González, B; Soto, I; Tenorio, M; Yera Cobo, M | 1 |
| Gornisiewicz, S; Shacham, S; Tamir, S; Widman, DG | 1 |
2 other study(ies) available for hydrazine and Virus Diseases
| Article | Year |
|---|---|
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.
Topics: Adult; Aged; Autoimmune Diseases; Benzoates; Drug Administration Schedule; Female; Humans; Hydrazines; Lymphoproliferative Disorders; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Retrospective Studies; Virus Diseases | 2017 |
In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
Topics: Acrylamides; Adenoviridae Infections; Animals; Cell Line, Tumor; Cytomegalovirus Infections; Drug Evaluation, Preclinical; Epstein-Barr Virus Infections; Exportin 1 Protein; Fibroblasts; Guinea Pigs; HEK293 Cells; HeLa Cells; HIV Infections; Humans; Hydrazines; Immunocompromised Host; Karyopherins; Mice; Papillomavirus Infections; Polyomavirus Infections; Receptors, Cytoplasmic and Nuclear; Reproducibility of Results; Sarcoma, Kaposi; Tumor Virus Infections; Virus Diseases | 2018 |